Document Detail


Portal vein thrombosis and liver abscess due to Lactococcus lactis.
MedLine Citation:
PMID:  16830302     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 26-year-old man was admitted with fever and abdominal pain. Abdominal ultrasonography and Doppler ultrasound eventually revealed portal vein thrombosis and a pyogenic liver abscess (17x11x11 cm). Lactococcus lactis was isolated from a culture of the abscess material. This organism is not a common pathogen in humans. This is the first published description of portal vein thrombosis and pyogenic liver abscess due to L. lactis.
Authors:
Galip Güz; Zeynep Arzu Yeğin; Ibrahim Doğan; Kenan Hizel; Musa Bali; Sükrü Sindel
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology     Volume:  17     ISSN:  1300-4948     ISO Abbreviation:  Turk J Gastroenterol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-07-10     Completed Date:  2009-02-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9515841     Medline TA:  Turk J Gastroenterol     Country:  Turkey    
Other Details:
Languages:  eng     Pagination:  144-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey. galip_guz@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Bacterial Agents / therapeutic use
Anticoagulants / therapeutic use
Catheterization
Drainage
Gram-Positive Bacterial Infections / microbiology*,  therapy,  ultrasonography
Heparin / therapeutic use
Humans
Lactococcus lactis / isolation & purification*
Liver Abscess / microbiology*,  therapy,  ultrasonography
Male
Microbial Sensitivity Tests
Portal Vein / microbiology*,  ultrasonography
Thienamycins / therapeutic use
Ultrasonography, Doppler
Venous Thrombosis / drug therapy,  microbiology*,  ultrasonography
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Anticoagulants; 0/Thienamycins; 81-81-2/Warfarin; 9005-49-6/Heparin; 96036-03-2/meropenem

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Macro-amylasemia in a patient with selective IgA deficiency and antiphospholipid antibodies.
Next Document:  Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure.